NVEC NVE CORP /NEW/

CIK 0000724910 17 ready 8-Ks latest May 6, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 17

Latest filing May 6, 2026, 7:59 PM ET

Top materiality 0.80

Event mix earnings ×10 · other_material ×4 · other ×2

Sentiment 4 pos · 5 neg · 8 neu

Latest earnings reported 2026-FY

Executive change recent →

Recent 8-K filings for NVEC

Highest-materiality recent filing

NVE Q4 revenue $7.08M (-45%), EPS $0.79; FY revenue $29.8M (-22%); declares $1.00 dividend

May 1, 2024, 7:59 PM ET earnings materiality 0.80 negative item 2.02 item 8.01 ◈ Earnings Releases

Q4 revenue $7.08M (-45% YoY); net income $3.81M ($0.79 EPS) down 54%.
FY2024 revenue $29.8M (-22% YoY); net income $17.1M ($3.54 EPS) down 25%.

Read filing →

May 6, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 8.01 ◈ Earnings Releases ×2

NVE Q4 revenue up 5% to $7.65M, EPS $1.02; declares $1.00 dividend

Q4 revenue $7.65M (+5% YoY); product sales up 6%, contract R&D down 19%.
January 21, 2026, 6:59 PM ET earnings materiality 0.65 positive item 2.02 item 8.01

NVE reports Q3 revenue up 23% to $6.22M, EPS $0.70 (+11% YoY); declares $1.00 dividend

Q3 total revenue $6.22M, up 23% from $5.06M; product sales +16%, contract R&D +335%.
December 17, 2025, 6:59 PM ET other material materiality 0.65 positive item 1.01

NVE extends Abbott supply agreement through 2027 with pricing increases for 2026-2027

Amendment No. 12 to Supplier Partnering Agreement with Pacesetter (Abbott) executed Dec 12, 2025.
October 22, 2025, 7:59 PM ET earnings materiality 0.60 negative item 2.02 item 8.01

NVE Q2 revenue down 6% to $6.35M; EPS $0.68 vs $0.83; declares $1.00 dividend

Total revenue $6.35M, down 6% YoY; product sales +1%, contract R&D -68%.
July 23, 2025, 7:59 PM ET earnings materiality 0.60 negative item 2.02 item 8.01

NVE Q1 revenue down 10% to $6.10M; EPS $0.74 vs $0.85; declares $1.00 dividend

Revenue $6.10M (down 10% YoY), net income $3.58M (down 13%); diluted EPS $0.74.
January 22, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 8.01

NVE Q3 revenue down 25% to $5.06M, net income falls 27% to $0.63 EPS; $1.00 dividend declared

Q3 total revenue $5.06M, down 25% YoY; product sales fell 22% and contract R&D revenue dropped 74%.
July 17, 2024, 7:59 PM ET earnings materiality 0.60 neutral item 2.02 item 8.01

NVE reports Q1 revenue down 23% to $6.78M, EPS $0.85 vs $0.91 prior year

Total revenue $6.78M, down 23% YoY; product sales fell 24%, contract R&D up 28%.
May 1, 2024, 7:59 PM ET earnings materiality 0.80 negative item 2.02 item 8.01 ◈ Earnings Releases

NVE Q4 revenue $7.08M (-45%), EPS $0.79; FY revenue $29.8M (-22%); declares $1.00 dividend

Q4 revenue $7.08M (-45% YoY); net income $3.81M ($0.79 EPS) down 54%.

Executive changes

Appointed

Kelly Wei

Director

NVEC · NVE CORP /NEW/

Effective: 2024-05-13
Filed: May 13, 2024, 7:59 PM ET

the NVE Board of Directors elected Kelly Wei, Ph.D. to join the Board effective May 13, 2024.

Departed

Richard W. Kramp

Director

NVEC · NVE CORP /NEW/

Effective: 2024-05-02
Successor: Kelly Wei
Filed: May 13, 2024, 7:59 PM ET

Director Richard W. Kramp passed away on May 2, 2024.

Earnings & guidance

2026-FY EPS reported $3.14 filing →

Materiality & sentiment trend

Max materiality 0.80 · Median 0.55 · Most common event earnings

4 positive 5 negative 8 neutral

source · NVEC on sec.gov